Purchase Order 75N93021P01367
- Not listed
- This federal contract award is for $14,072.00 and was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for pre-made libraries lane sequencing services, which involves advanced next-generation sequencing technologies including whole genome, transcriptome, metagenomic, and RNA sequencing. This contract has an ultimate completion date of June 30, 2025 and is a...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $17,010.00 on December 1, 2020, for mRNA sequencing services. Novogene is a minority-owned small business. Work is performed in Sacramento, California. The order is firm fixed price with an ultimate completion date of February 1, 2021.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $56,640 on August 19, 2021, for premade libraries and lane sequencing for NovaSeq PE 150 sequencing equipment. Novogene is a minority-owned small business based in Sacramento, California. Work is performed in Sacramento, California. The ultimate completion date is September 29, 2022. The solicitation was posted August 4, 2021, with a due date of August 11, 2021, and award date of...
- This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
- The National Institute of Allergy and Infectious Diseases awarded a $22,896 firm fixed-price purchase order to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California, for sequencing services relating to tick studies at the Rocky Mountain Laboratories. The contract was awarded on August 16, 2023, with an ultimate completion date of August 15, 2024, and carries no small business set-aside designation. Work will be performed in Sacramento, California. Novogene...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for plant and animal eukaryotic mRNA sequencing on March 16, 2022, with a ceiling value of $11,947.00 and ultimate completion date of April 15, 2022. Novogene is a minority-owned small business. Work is performed in Sacramento, California. The order is firm fixed price with no set-aside applied.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. on November 17, 2020, for mRNA sequencing services for innate immunity analysis, with a firm fixed price ceiling of $30,240. Novogene Corporation Inc. is a minority-owned small business. Work is performed in Sacramento, California. The order calls for mRNA sequencing services supporting innate immunity research. The ultimate completion date is January 15, 2021. The award resulted...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $11,820 firm fixed-price purchase order to Novogene Corporation Inc., a Sacramento, California-based minority-owned small business specializing in genomic sequencing and bioinformatics services. Awarded on September 9, 2021, with an ultimate completion date of September 28, 2022, this contract involved no small business set-aside. The award was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these federal funds. Novogene Corporation demonstrates extensive capabilities in next-generation sequencing technologies, including whole genome, transcriptome, metagenomic, and RNA sequencing services across multiple federal research agencies. The company has established a track record of supporting biomedical research through various contracting vehicles, including a significant blanket purchase agreement with the U.S. Geological Survey valued at $120,000 for microbial DNA and microRNA library preparation services. This NIAID purchase order represents part of the contractor's broader portfolio of federal genomic research support, leveraging the company's sophisticated scientific analysis capabilities for federal research institutions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Human mRNA sequencing services | NOI-NIAID-2087842 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Pre-Solicitation 1/1 | 8/30/21, 4:26 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($17k) | 3/2/26 | |
| P00001 | Other Administrative Action | $0 | 9/28/22 | |
| Not listed | Not listed | $28.6k | 9/9/21 |